Strengthening Aboriginal Capacity in Health Research Translation & Development in SA (StACTD)

Supporting Aboriginal and Torres Strait Islander researchers in health translation
Strengthening Aboriginal Capacity in Health Research Translation & Development in SA (StACTD)

SAHMRI is currently accepting StACTD program applications for 2023/24. This exciting program offers a way to upskill or reskill aspiring Aboriginal and/or Torres Strait Islander researchers in health translation.

StACTD is a support and development program that is open to Aboriginal and Torres Strait Islander people who live in South Australia and have a passion for improving the lives of Indigenous communities. The program aims to increase the number of Aboriginal and Torres Strait Islander people working, contributing to and leading health and medical research.

It might be suitable for people working in health services, working on research projects, or enrolled in or considering a Higher Degree by Research. Successful applicants will participate in a range of activities including career mapping to guide their path.

Eligibility criteria:

  • Identify as an Aboriginal and/or Torres Strait Islander person with confirmation of identity
  • Live in South Australia
  • Have a passion for improving the lives of Aboriginal and Torres Strait Islander people

SAHMRI's Wardliparingga Aboriginal Health Equity theme can provide foundational training to participants, giving them an overview of health research grounded in Aboriginal and Torres Strait Islander principles of research and ways of knowing, being and doing. Participants will be encouraged and financially supported to complete additional training related to health research translation that aligns with their interests including short workshops, online training modules, conference attendance and attainment of formal qualifications. Group and individual support such as mentoring and networking opportunities will also be available.

Apply for the 2023/24 StACTD Program

Click here

StACTD is supported by the Australian Government's Medical Research Future Fund as part of the Rapid Applied Research Translation program